Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001753420-23-000001
Filing Date
2023-10-03
Accepted
2023-10-03 15:15:41
Documents
1
Effectiveness Date
2023-10-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8153
  Complete submission text file 0001753420-23-000001.txt   9309
Mailing Address C/O ALEXANDRIA CENTER FOR LIFE SCIENCES LAUNCHLABS 430 E 29TH ST. 14TH FLOOR NEW YORK NY 100116
Business Address C/O ALEXANDRIA CENTER FOR LIFE SCIENCES LAUNCHLABS 430 E 29TH ST. 14TH FLOOR NEW YORK NY 100116 212 792-2317
ENB Therapeutics, Inc. (Filer) CIK: 0001753420 (see all company filings)

EIN.: 473954174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-493707 | Film No.: 231302998